IMARC Group’s report titled “Vertebroplasty and Kyphoplasty Needles Market Report by Procedure (Kyphoplasty Procedures, Vertebroplasty Procedures), End Use (Hospitals, Ambulatory Surgical Centers), and Region 2024-2032“. The global vertebroplasty and kyphoplasty needles market size reached US$ 884.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,334.2 Million by 2032, exhibiting a growth rate (CAGR) of 4.68% during 2024-2032.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/vertebroplasty-kyphoplasty-needles-market/requestsample
Factors Affecting the Growth of the Vertebroplasty and Kyphoplasty Needles Industry:
- Increasing Prevalence of Osteoporosis and Vertebral Compression Fractures:
The rising occurrence of osteoporosis and vertebral compression fractures among the masses is propelling the market growth. These conditions, primarily affecting the elderly population, are driving the demand for minimally invasive (MI) surgical procedures, such as vertebroplasty and kyphoplasty. These procedures are favored for their benefits in pain relief and spinal stabilization, making them crucial in the management of osteoporotic fractures. This is supported by healthcare initiatives focused on bone health and the prevention of fractures, emphasizing the importance of early intervention and the adoption of effective treatment modalities like vertebroplasty and kyphoplasty.
- Technological Advancements in Surgical Equipment:
Innovations in needle design and functionality, such as improved precision, biocompatibility, and the introduction of materials that enhance durability and performance, are contributing to the effectiveness and safety of vertebroplasty and kyphoplasty procedures. These advancements facilitate easier navigation through the vertebral body, reducing procedure time and enhancing patient outcomes. Additionally, the integration of imaging techniques with surgical instruments is improving the accuracy of needle placement, minimizing complications and promoting faster recovery. Manufacturers are continuously investing in research and development (R&D), which is resulting in the introduction of more sophisticated solutions, further driving adoption among healthcare providers.
- Growing Awareness and Acceptance of Minimally Invasive (MI) Procedures:
The increasing awareness and acceptance of minimally invasive (MI) procedures among both healthcare professionals and patients is offering a favorable market outlook. MI spine surgeries, including vertebroplasty and kyphoplasty, offer numerous advantages over traditional open surgeries, such as reduced pain, lower risk of infection, shorter hospital stays, and quicker recovery times. This shift towards less invasive treatment options is supported by a growing body of clinical evidence demonstrating their efficacy and safety in managing vertebral compression fractures. Healthcare systems worldwide are adopting these techniques, driven by patient preference for less invasive interventions and the potential for cost savings.
Leading Companies Operating in the Global Vertebroplasty and Kyphoplasty Needles Industry:
- Adroit Manufacturing Company
- Biopsybell S.R.L. Società Unipersonale
- IZI Medical Products (Halma plc)
- Jayon Implants Pvt.Ltd.
- Medtronic Plc
- Merit Medical Systems, Inc.
- MOLLER Medical GmbH
- Stryker Corporation
- Suretech Medical INC
- Swastik Enterprise
- Tecres S.p.A.
- Teknimed
Vertebroplasty and Kyphoplasty Needles Market Report Segmentation:
By Procedure:
- Kyphoplasty Procedures
- Vertebroplasty Procedures
Kyphoplasty procedures represent the largest segment, as they not only stabilize the bone but also help restore the vertebral body height, making them more appealing for treating vertebral compression fractures.
By End Use:
- Hospitals
- Ambulatory Surgical Centers
Hospitals account for the majority of the market share owing to their crucial role in performing various surgical procedures.
Regional Insights:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
North America dominates the market due to the existence of advanced healthcare infrastructure, the high prevalence of osteoporosis, and the growing elderly population that is more susceptible to vertebral fractures.
Global Vertebroplasty and Kyphoplasty Needles Market Trends:
The growing integration of smart technologies and digital health solutions to enhance procedural outcomes and patient experiences is positively influencing the market. This includes the development of needles equipped with sensors and connectivity features that can provide real-time feedback on the placement and cement distribution during procedures.
Additionally, the use of artificial intelligence (AI) and machine learning (ML) algorithms for predictive analytics in patient selection and procedural planning is gaining traction. These technologies can help in identifying patients who are most likely to benefit from vertebroplasty or kyphoplasty, thereby optimizing treatment outcomes and reducing the risk of complications.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145